Completed
The DREAM (Diabetes Reduction Assessment With Ramipril and Rosiglitazone Medication) Trial
NCT00095654
- Conditions
- Cardiovascular Disease, Cardiovascular Diseases, Glucose Intolerance, +5 more
- Locations
-
Not specified